APA Citation

Tavori, H., Giunzioni, I., Predazzi, I. M., Plubell, D., Shivinsky, A., Miles, J., . . . Fazio, S. (2016). Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms. Cardiovasc Res.

Citação norma Chicago

Tavori, Hagai, et al. "Human PCSK9 Promotes Hepatic Lipogenesis and Atherosclerosis Development Via ApoE- and LDLR-mediated Mechanisms." Cardiovasc Res 2016.

MLA Citation

Tavori, Hagai, et al. "Human PCSK9 Promotes Hepatic Lipogenesis and Atherosclerosis Development Via ApoE- and LDLR-mediated Mechanisms." Cardiovasc Res 2016.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.